The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
about
Tumour-associated macrophages secrete pleiotrophin to promote PTPRZ1 signalling in glioblastoma stem cells for tumour growthALK-driven tumors and targeted therapy: focus on crizotinibIncreased Pleiotrophin Concentrations in Papillary Thyroid Cancer.Integrative Network Analysis Combined with Quantitative Phosphoproteomics Reveals Transforming Growth Factor-beta Receptor type-2 (TGFBR2) as a Novel Regulator of Glioblastoma Stem Cell Properties.The EGF Receptor Promotes the Malignant Potential of Glioma by Regulating Amino Acid Transport System xc(-)GBM-associated mutations and altered protein expression are more common in young patients.Systemic treatment in EGFR-ALK NSCLC patients: second line therapy and beyond.The glioblastoma vasculature as a target for cancer therapy.Expression of SOX2 in oral squamous cell carcinoma and the association with lymph node metastasisPleiotrophin, a target of miR-384, promotes proliferation, metastasis and lipogenesis in HBV-related hepatocellular carcinoma.Pleiotrophin enhances PDGFB-induced gliomagenesis through increased proliferation of neural progenitor cells.Expression of sex-determining region Y-box protein 2 in breast cancer and its clinical significance.Pleiotrophin promotes chemoresistance to doxorubicin in osteosarcoma by upregulating P-glycoproteinCrizotinib targets in glioblastoma stem cells.Targeting Autophagy in ALK-Associated Cancers.
P2860
Q33770873-A7A371B2-BF29-4447-BD6B-5DD5DCB08F06Q34414378-80DDBAC8-679F-4F82-AD5E-DF97C33809AFQ35935584-51026784-B82E-490D-A626-E7132E083B7EQ36745073-28EEC70F-372F-4663-9553-C8A68E939B69Q36917721-684F9A28-C123-446B-A214-5E1E54DAC00AQ37688393-25D10B4F-F06E-468C-AAFA-D64B13CF9FA7Q38264440-82B20DB8-33CD-4303-A88B-3983BC111552Q38268463-B6C5B794-659C-4DD1-9F64-36F889D60DFAQ38719678-192B3A11-8C31-48BA-91FE-B8A380BC8F68Q38756799-F49D854B-04A9-45B9-B8F8-09E1B3C67089Q39223541-4BBD0644-E70C-4568-BBF3-CC7B6156CA3FQ41391131-D9FE04C1-7DD2-4BF4-98E8-ED38DE7D1C97Q42091398-6BE706B0-03B7-4776-AE03-BAE4BCFA4A5CQ47122191-E87C286D-B115-4817-BB73-94D89460AA08Q49545616-F7A7DBCE-5F66-4796-863A-311BA384C2EB
P2860
The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
@en
The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
@nl
type
label
The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
@en
The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
@nl
prefLabel
The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
@en
The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
@nl
P2093
P2860
P356
P1433
P1476
The pleiotrophin-ALK axis is required for tumorigenicity of glioblastoma stem cells.
@en
P2093
A Hoshino-Okubo
K Shirahige
P2860
P2888
P304
P356
10.1038/ONC.2013.168
P407
P577
2013-05-20T00:00:00Z